secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0000950170-22-011164
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta shareholders approve 2.5M share increase to 2018 equity plan
--------------------------------------------------------------------

- Shareholders approved 2018 Plan Amendment, increasing authorized shares by 2.5M to 10,687,596.
- All four Class I director nominees elected: Boor, Chambers, Ingram, Wigzell.
- Advisory say-on-pay passed with 62,746,933 for (93.2% of votes cast).
- KPMG ratified as independent auditor for 2022 with 73,729,807 for.
- Equity plan vote: 62,644,364 for, 4,572,292 against, 55,530 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000095017022011164/0000950170-22-011164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000095017022011164/srpt-20220602.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer